Don't invest unless you're prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.
Access EIS investments for December 2022 and January 2023
Between December and January, we added three new startups to the Access EIS portfolio, investing alongside super angels in each case (for more on our super angels, and our co-investment model, see our dedicated page. Find out more about our fund, Access EIS, or read about our new portfolio companies below.
Incard is a payment solution designed exclusively for e-commerce, entrepreneurs, dropshippers and influencers. It facilitates faster international payments, allows the issue of virtual cards for employees and integrates with digital platforms. It also comes with built-in accounting software as part of the Incard app.
Our angel partner in the round has an IRR of 44% and has invested into Hadean, Converge and AimBrain among others.
Total Round: approx.£750,000.
Stage Pre-revenue.
Five Alarm Bio develops anti-ageing therapeutics designed to help extend the lifecycle of cells and to avoid illnesses associated with ageing.
Our angel partner in the round has an weighted IRR of 66% and has invested into Geospock, Healx and Gelmetix among others.
Total Round: approx. £510,000.
Stage Pre-revenue.
Itza develops software and offers educational services with the aim of making online and digital learning more engaging. Its first product, GET SET, is currently in beta.
Our angel partner in the round has an weighted IRR of 33% and has invested into Unmind, Percent and The Car Finance Company among others.
Total Round: approx. £3,000,000.
Stage Pre-revenue.
